|
UroxatralDrug - Uroxatral The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Alfuzosin Hydrochloride
Strength -
10MG
Applicant -
SANOFI SYN RES
New Drug Application (NDA) Number -
021287
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 12, 2003
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Sanofi Synthelabo Research Div Sanofi Synthelabo Inc
Uroxatral
Fosamax Eq 70mg Base Tablet; Oral
Fosamax Plus D Eq 70mg Base;2,800 Iu Tablet; Oral Alfenta Eq 0.5mg Base/ml Injectable; Injection Alfentanil Eq 0.5mg Base/ml Injectable; Injection Uroxatral 10mg Tablet, Extended Release; Oral Fosamax Eq 70mg Base/75ml Solution; Oral Fosamax Eq 10mg Base Tablet; Oral Fosamax Eq 35mg Base Tablet; Oral Fosamax Eq 40mg Base Tablet; Oral Fosamax Eq 5mg Base Tablet; Oral NewDrugInformation |